PBX1 and acute lymphoblastic leukemia: Dysregulation of the Wnt/β-catenin pathway is involved in B-ALL development as demonstrated in a pre-B ALL subtype characterized by (1;19) translocation, where Wnt16b was hyper-activated by the expression of the aberrant E2A-Pbx1 fusion protein.